Clinical Trials Browser

Phase 2 × Active not recruiting × Testosterone Propionate × Clear all

NCT00080756 2024-08-28

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

Phase 2 Active not recruiting

Breast Neoplasms